The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation
- PMID: 11035045
- DOI: 10.1074/jbc.M009134200
The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation
Abstract
The tumor suppressor phosphatase PTEN regulates cell migration, growth, and survival by dephosphorylating phosphatidylinositol second messengers and signaling phosphoproteins. PTEN possesses a C-terminal noncatalytic regulatory domain that contains multiple putative phosphorylation sites, which could play an important role in the control of its biological activity. The protein kinase CK2 phosphorylated, in a constitutive manner, a cluster of Ser/Thr residues located at the PTEN C terminus. PTEN-phosphorylated defective mutants showed decreased stability in comparison with wild type PTEN and were more rapidly degraded by the proteasome. Inhibition of PTEN phosphorylation by the CK2 inhibitor 5,6-dichloro-1-beta-d-ribofuranosyl-benzimidazole also diminished the PTEN protein content. Our results support the notion that proper phosphorylation of PTEN by CK2 is important for PTEN protein stability to proteasome-mediated degradation.
Similar articles
-
Direct identification of PTEN phosphorylation sites.FEBS Lett. 2002 Sep 25;528(1-3):145-53. doi: 10.1016/s0014-5793(02)03274-x. FEBS Lett. 2002. PMID: 12297295
-
Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.Am J Pathol. 2002 Feb;160(2):511-9. doi: 10.1016/S0002-9440(10)64870-5. Am J Pathol. 2002. PMID: 11839571 Free PMC article.
-
Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells.J Biol Chem. 2003 Jul 25;278(30):28258-63. doi: 10.1074/jbc.M303318200. Epub 2003 May 12. J Biol Chem. 2003. PMID: 12743124
-
The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.Biochim Biophys Acta. 2000 Feb 14;1470(1):M21-35. doi: 10.1016/s0304-419x(99)00032-3. Biochim Biophys Acta. 2000. PMID: 10656987 Review. No abstract available.
-
Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases.Biochem Soc Trans. 2004 Apr;32(Pt 2):348-9. doi: 10.1042/bst0320348. Biochem Soc Trans. 2004. PMID: 15046606 Review.
Cited by
-
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review.Front Immunol. 2024 May 10;15:1389971. doi: 10.3389/fimmu.2024.1389971. eCollection 2024. Front Immunol. 2024. PMID: 38799440 Free PMC article.
-
Regulation of cancer progression by CK2: an emerging therapeutic target.Med Oncol. 2024 Mar 25;41(5):94. doi: 10.1007/s12032-024-02316-6. Med Oncol. 2024. PMID: 38526625 Review.
-
Distinct early role of PTEN regulation during HCMV infection of monocytes.Proc Natl Acad Sci U S A. 2024 Mar 19;121(12):e2312290121. doi: 10.1073/pnas.2312290121. Epub 2024 Mar 14. Proc Natl Acad Sci U S A. 2024. PMID: 38483999
-
CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis.Hemasphere. 2023 Nov 23;7(12):e978. doi: 10.1097/HS9.0000000000000978. eCollection 2023 Dec. Hemasphere. 2023. PMID: 38026791 Free PMC article.
-
PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.J Exp Clin Cancer Res. 2023 Nov 9;42(1):295. doi: 10.1186/s13046-023-02823-w. J Exp Clin Cancer Res. 2023. PMID: 37940999 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
